Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2025ProcessesOpen Access

Targeting GPR55 with Cannabidiol Derivatives: A Molecular Docking Approach Toward Novel Neurotherapeutics

View Full Paper
Ask AI
Bookmark
Share

Authors

CMCătălina MareşAPAndra-Maria PaunMMMaria Mernea

Discussion

Loading...

Member takes

Overview

Bioinformatics analysis reveals CBD derivatives may effectively bind to GPR55 in CNS conditions, suggesting therapeutic potential.

Key Points

  • Strong binding affinities of CBD derivatives to GPR55 suggest promising therapeutic applications in CNS.
  • Molecular docking scores between −9.2 and −7.2 kcal/mol demonstrate thermodynamically favorable interactions.
  • Key residues in GPR55's binding pocket indicate a structurally defined site for cannabinoid interaction.
  • Moderate oral bioavailability (0.55) implies potential for enhanced drug formulations targeting GPR55.

Cite This Study

Mareş et al. (2025) studied this question.

synapsesocial.com/papers/68f04920e559138a1a06d992https://doi.org/10.3390/pr13103261
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy2015 · 492 citations
  2. 2Bioinformatics Tools for the Analysis of Active Compounds Identified in Ranunculaceae Species2023 · 12 citations
  3. 3CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field2015 · 4,461 citations
  4. 4Structural insight into GPR55 ligand recognition and G-protein coupling2024 · 19 citations